Harvard Bioscience Announces Second Quarter 2025 Financial Results — Neutral
HBIO GlobeNewsWire — August 11, 2025Reports Q2 2025 Revenues of $20.5M, Gross Margin of 56.4%, and Positive Cash Provided by Operations Third Quarter 2025 Guidance Reflects Improved Operations and Strong Financial Discipline New Credit Amendment Signed, Extending Refinance Deadline to December 5th HOLLISTON, Mass., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter and six months ended June 30, 2025.
Appoints 25-Year OpenText Veteran James McGourlay as Interim Chief Executive Officer Board of Directors Establishes Executive Committee and Commences CEO Search Company to Continue to Explore Portfolio-Shaping Opportunities to Enhance Focus WATERLOO, ON , Aug. 11, 2025 /PRNewswire/ -- Open Text Corporation (NASDAQ: OTEX) (TSX: OTEX) ("OpenText" or the "Company") today announced the appointment of James McGourlay, currently Executive Vice President, International Sales at OpenText, as Interim Chief Executive Officer, effective immediately. Mr. McGourlay has been with the Company for more than 25 years and has held senior roles in sales, customer operations, IT, technical support, product support and special …
Engine Capital Sends Letter to Avantor's Board of Directors Regarding Opportunities to Improve Governance and Unlock Shareholder Value — Neutral
AVTR Business Wire — August 11, 2025NEW YORK--(BUSINESS WIRE)--Engine Capital LP (together with its affiliates, “Engine” or “we”), which owns approximately 3% of the outstanding shares of Avantor, Inc. (NYSE: AVTR) (“Avantor” or the “Company”), today sent a letter to the Company's Board of Directors outlining several opportunities to close Avantor's significant valuation gap and unlock value for shareholders. The letter can be viewed and downloaded here. About Engine Capital Engine Capital LP is a value-oriented special situation.
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2025 — Neutral
IMVT GlobeNewsWire — August 11, 2025NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today reported corporate updates and financial results for the quarter ended June 30, 2025.
Roivant Reports Financial Results for the First Quarter Ended June 30, 2025, and Provides Business Update — Neutral
ROIV GlobeNewsWire — August 11, 2025BASEL, Switzerland and LONDON and NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the first quarter ended June 30, 2025, and provided a business update.
Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome — Neutral
BIIB GlobeNewsWire — August 11, 2025– Global, pivotal Phase 3 study will evaluate efficacy and safety of zorevunersen compared to sham over a 52-week treatment period –
Kymera Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Business Update — Neutral
KYMR GlobeNewsWire — August 11, 2025Reported positive KT-621 (STAT6) Phase 1 healthy volunteer data surpassing Kymera's target product profile, and further validating its oral, dupilumab-like profile
RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that Dr. Helen Thackray, chief research and development officer, will leave the company September 1, 2025 and transition into an advisory role through the end of the year.
JXI: Global Diversification At Lower Multiples For A Better Performance — Positive
JXI Seeking Alpha — August 11, 2025I rate iShares Global Utilities ETF a buy, as utilities offer both defensive stability and growth from decarbonization and rising global energy demand. JXI stands out for its global diversification and lower company-specific risk compared to U.S.-focused peers like XLU and FUTY. Despite a higher expense ratio, JXI trades at lower valuation multiples and has outperformed peers over the last three years.
Powerfleet Announces New Major Partnership with MTN Business to Scale AIoT Adoption Across Extensive Enterprise Operations — Neutral
AIOT PRNewsWire — August 11, 2025Combined Platform and Connectivity Strength Unlocks Predictive, AI and Data-Led Intelligence for Fixed and Mobile Operations WOODCLIFF LAKE, N.J. , Aug. 11, 2025 /PRNewswire/ -- Powerfleet, Inc. (Nasdaq: AIOT), a global leader in the artificial intelligence of things (AIoT) SaaS mobile asset industry, today announced a groundbreaking new enterprise growth partnership with MTN Business South Africa, part of MTN Group, the continent's largest mobile network operator, with 297 million customers across 16 markets and $7.4 billion in annual revenue.
FMC Corporation: Dividend Cash Cow Trading At Decade-Low Prices — Positive
FMC Seeking Alpha — August 11, 2025FMC is trading near decade-low levels, offering a compelling margin of safety even with conservative growth assumptions and current cyclical headwinds. The company's financial position remains solid, with manageable debt and strong free cash flow potential once working capital normalizes. Dividend yield is attractive at over 6%, though a cut to a more sustainable level is possible in the near-term, but would still offer appealing income.
Western Union Expands Retail Footprint With $500 Million Intermex Deal — Positive
WU PYMNTS — August 11, 2025Western Union is acquiring money transfer service International Money Express (Intermex) for $500 million. The deal is designed to bolster Western Union's retail business in the U.S. while helping it speed digital customer acquisition, the company said in a Sunday (Aug. 10) news release.
VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG”, or the “Company”) announces the Company's unaudited consolidated financial results for the three months ended June 30, 2025 (“Q2 2025”). For details of the unaudited condensed interim consolidated financial statements of the Company for the three and six months ended June 30, 2025 (“Q2 2025 Financial Statements”) and management's discussion and analysis for the three and six months ended June 30, 2025 (“Q2 2025 MD&A”), please see the Company's filings on the System for Electronic Document Analysis and Retrieval Plus (“SEDAR+”) at …
AMC Entertainment Holdings, Inc. Reports Second Quarter 2025 Results — Neutral
AMC Business Wire — August 11, 2025LEAWOOD, Kan.--(BUSINESS WIRE)---- $AMC--AMC Entertainment Holdings, Inc. (NYSE: AMC) (“AMC” or “the Company”) today reported results for the second quarter ended June 30, 2025, which have been posted to the Investor Relations section of AMC's website at https://investor.amctheatres.com/. The Company will host a live webcast for investors and other interested parties on August 11, 2025, at 4:00 PM CDT/5:00 PM EDT. The live webcast can be accessed through the Investor Relations section of AMC's website a.
Kolibri Global Energy Inc. Announces Production Increase for the Second Quarter and Anticipates Significantly Higher Production From 9 New Wells in the Second Half of 2025 — Neutral
KGEI Business Wire — August 11, 2025THOUSAND OAKS, Calif.--(BUSINESS WIRE)--All amounts are in U.S. Dollars unless otherwise indicated: SECOND QUARTER HIGHLIGHTS Average production for the second quarter of 2025 was 3,220 BOEPD, an increase of 3% compared to the second quarter of 2024 average production of 3,128 BOEPD. The increase was due to production from the wells that were drilled and completed in the last half of 2024, partially offset by decreased production from wells that were shut-in during the completion operations for.
Medical Properties Trust: Still Wouldn't Touch It With A 10-Foot Pole — Positive
MPW Seeking Alpha — August 11, 2025Medical Properties Trust has made some operational improvements, but the turnaround remains slow, and significant upside is unlikely in the near to medium term. Recent earnings showed modest revenue and FFO growth, but ongoing impairment charges and tenant bankruptcies continue to pressure financials. Normalized FFO and revenues are down year-over-year, with analyst expectations for 2025 and beyond reflecting only incremental progress.
Alibaba's decade-long underperformance highlights the risks of Chinese stocks, but extreme negative sentiment creates a contrarian opportunity. The company's aggressive 'all-in AI' pivot, leadership in open-source models, and cloud growth position it as a top AI player in China. Despite competitive pressures, Alibaba remains highly profitable, with strong financials and a valuation far below global AI peers.
Trump Has Put Nvidia, AMD, China in a Jam. How It Plays Out for Markets. — Negative
AMD NVDA Barrons — August 11, 2025Inflation data coming this week, Tesla's third-quarter sales get a boost, private markets fintech iCapital hires Bloomberg vet, and more news to start your day.
MSTY: Fails From A Structural Standpoint, Works From An Investor Pshychology Perspective — Negative
MSTY Seeking Alpha — August 11, 2025The Yieldmax MSTR Option Income Strategy ETF (MSTY) is an actively managed fund that aims to generate monthly income by selling call and put options on MicroStrategy (MSTR). From a performance standpoint, MSTY has failed to keep up with a direct investment in MSTR. MSTR was up 191% over the last year vs 130% for MSTY. MSTY is perceived as a fixed-income product due to its high monthly dividends, even though its distributions are derived from equity option strategies, not traditional cash flows.
Snap: Weighing The Risks And Rewards After The Q2 Correction — Neutral
SNAP Seeking Alpha — August 11, 2025Snap's user and subscription growth is positive but too slow to drive a meaningful pivot toward profitability in the near term. Ad revenue growth guidance is optimistic, but macro headwinds and a lack of immediate catalysts limit upside potential. Valuation appears cheap, but ongoing losses and high execution risks make Snap a potential value trap rather than a deep value buy.